This inventor holds 2 USPTO granted patents and 3 published patent applications. Top assignee: Laurus Labs Private Limited. Active years: 2018-2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2020
Title: Innovations by Srinivas Benda in Pharmaceutical Chemistry
Introduction
Srinivas Benda is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the synthesis of important compounds. With a total of 2 patents to his name, Benda's work is recognized for its innovative approaches and practical applications.
Latest Patents
One of his latest patents is focused on the "Process for the preparation of enzalutamide." This invention presents an improved method for synthesizing enzalutamide through conventional techniques, eliminating the need for microwave irradiation and harmful reagents. Additionally, he has developed a process for the preparation of 4-isothiocyanato-2-(trifluoromethyl) benzonitrile, which serves as an intermediate in the synthesis of enzalutamide. This advancement highlights his commitment to enhancing the efficiency and safety of pharmaceutical production.
Career Highlights
Srinivas Benda is currently associated with Laurus Labs Private Limited, a prominent company in the pharmaceutical sector. His role at Laurus Labs has allowed him to apply his expertise in drug development and synthesis, contributing to the company's innovative projects and research initiatives.
Collaborations
Throughout his career, Benda has collaborated with talented professionals in the field. Notable coworkers include Dharmapuri Gajula and Satyanarayana Chava, who have worked alongside him on various projects, further enriching the collaborative environment at Laurus Labs.
Conclusion
Srinivas Benda's contributions to pharmaceutical chemistry through his patents and work at Laurus Labs demonstrate his innovative spirit and dedication to advancing drug synthesis methods. His inventions not only improve existing processes but also pave the way for future developments in the industry.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
